Cargando…

Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis

PURPOSE: To report a rare case of a unilateral choroidal mast cell infiltration in a patient with aggressive systemic mastocytosis (ASM). OBSERVATIONS: The patient is a man in his fifties with a diagnosis of ASM. He developed visual complaints in the right eye associated with an area of subretinal f...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Tu M., Najafi, Mehdi, Ambros, Tadeu, Pulido, Jose S., Ustun, Celalettin, Koozekanani, Dara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021538/
https://www.ncbi.nlm.nih.gov/pubmed/32083227
http://dx.doi.org/10.1016/j.ajoc.2020.100614
_version_ 1783497896974352384
author Tran, Tu M.
Najafi, Mehdi
Ambros, Tadeu
Pulido, Jose S.
Ustun, Celalettin
Koozekanani, Dara
author_facet Tran, Tu M.
Najafi, Mehdi
Ambros, Tadeu
Pulido, Jose S.
Ustun, Celalettin
Koozekanani, Dara
author_sort Tran, Tu M.
collection PubMed
description PURPOSE: To report a rare case of a unilateral choroidal mast cell infiltration in a patient with aggressive systemic mastocytosis (ASM). OBSERVATIONS: The patient is a man in his fifties with a diagnosis of ASM. He developed visual complaints in the right eye associated with an area of subretinal fluid on fundus examination. Visual acuity at presentation was 20/150 in the right eye and 20/25 in the left eye. After ophthalmic and radiologic imaging workup, the patient was diagnosed with presumed choroidal mast cell infiltrate. The index of suspicion was high due to the prior ASM diagnosis. External beam radiation and intravitreal injection treatments were offered but the patient declined. The patient was switched from interferon to a new targeted systemic therapy for ASM, midostaurin. Despite some mixed, temporary response in systemic symptoms/signs of ASM at four months, the choroidal lesion and subretinal fluid were stable with visual acuity at 20/125. CONCLUSION AND IMPORTANCE: Mast cell choroidal infiltration in ASM should be considered as part of the differential with acute/subacute vision changes. Diagnosis requires exclusion of other possibilities with ocular imaging and in this case, monitoring for development of other malignancies in which there were none. Midostaurin's ocular response was not on par with systemic response. Additional localized ocular therapies may be required.
format Online
Article
Text
id pubmed-7021538
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-70215382020-02-20 Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis Tran, Tu M. Najafi, Mehdi Ambros, Tadeu Pulido, Jose S. Ustun, Celalettin Koozekanani, Dara Am J Ophthalmol Case Rep Case Report PURPOSE: To report a rare case of a unilateral choroidal mast cell infiltration in a patient with aggressive systemic mastocytosis (ASM). OBSERVATIONS: The patient is a man in his fifties with a diagnosis of ASM. He developed visual complaints in the right eye associated with an area of subretinal fluid on fundus examination. Visual acuity at presentation was 20/150 in the right eye and 20/25 in the left eye. After ophthalmic and radiologic imaging workup, the patient was diagnosed with presumed choroidal mast cell infiltrate. The index of suspicion was high due to the prior ASM diagnosis. External beam radiation and intravitreal injection treatments were offered but the patient declined. The patient was switched from interferon to a new targeted systemic therapy for ASM, midostaurin. Despite some mixed, temporary response in systemic symptoms/signs of ASM at four months, the choroidal lesion and subretinal fluid were stable with visual acuity at 20/125. CONCLUSION AND IMPORTANCE: Mast cell choroidal infiltration in ASM should be considered as part of the differential with acute/subacute vision changes. Diagnosis requires exclusion of other possibilities with ocular imaging and in this case, monitoring for development of other malignancies in which there were none. Midostaurin's ocular response was not on par with systemic response. Additional localized ocular therapies may be required. Elsevier 2020-02-04 /pmc/articles/PMC7021538/ /pubmed/32083227 http://dx.doi.org/10.1016/j.ajoc.2020.100614 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Tran, Tu M.
Najafi, Mehdi
Ambros, Tadeu
Pulido, Jose S.
Ustun, Celalettin
Koozekanani, Dara
Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis
title Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis
title_full Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis
title_fullStr Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis
title_full_unstemmed Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis
title_short Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis
title_sort presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021538/
https://www.ncbi.nlm.nih.gov/pubmed/32083227
http://dx.doi.org/10.1016/j.ajoc.2020.100614
work_keys_str_mv AT trantum presumedmastcellchoroidalinfiltrateinaggressivesystemicmastocytosis
AT najafimehdi presumedmastcellchoroidalinfiltrateinaggressivesystemicmastocytosis
AT ambrostadeu presumedmastcellchoroidalinfiltrateinaggressivesystemicmastocytosis
AT pulidojoses presumedmastcellchoroidalinfiltrateinaggressivesystemicmastocytosis
AT ustuncelalettin presumedmastcellchoroidalinfiltrateinaggressivesystemicmastocytosis
AT koozekananidara presumedmastcellchoroidalinfiltrateinaggressivesystemicmastocytosis